Literature DB >> 12111567

Rapid detection of quinolone resistance-associated gyrA mutations in Neisseria gonorrhoeae with a LightCycler.

Zhiyu Li1, Shigeaki Yokoi, Yoshiaki Kawamura, Shin-Ichi Maeda, Takayuki Ezaki, Takashi Deguchi.   

Abstract

Afluorometric real-time polymerase chain-reaction (PCR)-hybridization system, the LightCycler was developed for the detection of Neisseria gonorrhoeae in clinical samples and the analysis of point mutations associated with quinolone resistance in the gyrAgene. This system allowed us to amplify the N. gonorrhoeae-specific gyrA gene from an amount of DNA corresponding to five genome copies per reaction. We were able to detect N. gonorrhoeae in either 55 control strains or 36 nonisolated clinical urethral swab specimens, and to analyze the presence of mutations in codons Ser-91 and Asp-95 of the gyrA gene within 1 h. The mutation status in the gyrA gene assessed by the LightCycler assay was completely in agreement with the results of our previous conventional sequencing analysis, and was associated with the susceptibility to ciprofloxacin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12111567     DOI: 10.1007/s101560200025

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  14 in total

1.  Use of applied biosystems 7900HT sequence detection system and Taqman assay for detection of quinolone-resistant Neisseria gonorrhoeae.

Authors:  Julie Giles; Justin Hardick; Jeffrey Yuenger; Michael Dan; Karl Reich; Jonathan Zenilman
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

2.  Gonorrhea Update.

Authors:  Margaret C. Bash
Journal:  Curr Infect Dis Rep       Date:  2004-04       Impact factor: 3.725

Review 3.  Nucleic acid amplification testing for Neisseria gonorrhoeae: an ongoing challenge.

Authors:  David M Whiley; John W Tapsall; Theo P Sloots
Journal:  J Mol Diagn       Date:  2006-02       Impact factor: 5.568

Review 4.  Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future.

Authors:  Magnus Unemo; William M Shafer
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

5.  Multiplex Real-Time PCR Assay for Simultaneous Identification of Neisseria gonorrhoeae and Its Ciprofloxacin Susceptibility Status.

Authors:  Sumudu R Perera; Nurul H Khan; Irene Martin; Ali Taheri; Rajinder P Parti; Paul N Levett; Greg B Horsman; Anthony Kusalik; Jo-Anne R Dillon
Journal:  J Clin Microbiol       Date:  2017-08-16       Impact factor: 5.948

6.  Real-time PCR assay for detection of quinolone-resistant Neisseria gonorrhoeae in urine samples.

Authors:  Mark J Siedner; Mark Pandori; Lina Castro; Pennan Barry; William L H Whittington; Sally Liska; Jeffrey D Klausner
Journal:  J Clin Microbiol       Date:  2007-01-31       Impact factor: 5.948

7.  Antibiograms and randomly amplified polymorphic DNA-polymerase chain reactions (RAPD-PCR) as epidemiological markers of gonorrhea.

Authors:  Ratana Lawung; Angkana Charoenwatanachokchai; Rungrot Cherdtrakulkiat; Sivarak Thammapiwan; Tharinda Mungniponpan; Leif Bülow; Virapong Prachayasittikul
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

8.  Real-time PCR assay for detection of fluoroquinolone resistance associated with grlA mutations in Staphylococcus aureus.

Authors:  Pascal Lapierre; Ann Huletsky; Véronique Fortin; François J Picard; Paul H Roy; Marc Ouellette; Michel G Bergeron
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

Review 9.  The use of cephalosporins for gonorrhea: the impending problem of resistance.

Authors:  Pennan M Barry; Jeffrey D Klausner
Journal:  Expert Opin Pharmacother       Date:  2009-03       Impact factor: 3.889

10.  Quinolone resistance in Neisseria gonorrhoeae: rapid genotyping of quinolone resistance-determining regions in gyrA and parC genes by melting curve analysis predicts susceptibility.

Authors:  Frédérique Vernel-Pauillac; Tiffany R Hogan; John W Tapsall; Cyrille Goarant
Journal:  Antimicrob Agents Chemother       Date:  2009-01-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.